Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy: pulmonary and vascular endothelial function-an exploratory analysis.

Autor: van der Schoot GGF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Ormel HL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Westerink NL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Wempe JB; Department of Pulmonary Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Lefrandt JD; Department of Vascular Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Vrieling AH; Department of Rehabilitation Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Meijer C; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands., Walenkamp AME; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. a.walenkamp@umcg.nl.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Dec; Vol. 149 (19), pp. 17467-17478. Date of Electronic Publication: 2023 Oct 27.

Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness: During or After Chemotherapy.

Autor: van der Schoot GGF; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Ormel HL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Westerink NL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., May AM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Elias SG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Hummel YM; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Lefrandt JD; Department of Vascular Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van der Meer P; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van Melle JP; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Poppema BJ; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Internal Medicine, Ommelander Hospital Groningen, Scheemda, the Netherlands., Stel JMA; Department of Rehabilitation Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van der Velden AWG; Department of Internal Medicine, Martini Hospital Groningen, Groningen, the Netherlands., Vrieling AH; Department of Rehabilitation Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Wempe JB; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Ten Wolde MG; Department of Rehabilitation Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Nijland M; Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Gietema JA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Walenkamp AME; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2022 Oct 18; Vol. 4 (4), pp. 491-503. Date of Electronic Publication: 2022 Oct 18 (Print Publication: 2022).

Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study.

Autor: Ormel HL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., van der Schoot GGF; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Westerink NL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., van der Velden AWG; Department of Internal Medicine, Martini Hospital Groningen, Groningen, the Netherlands., Poppema B; Department of Internal Medicine, Ommelander Hospital Group, Scheemda, the Netherlands., Vrieling AH; Department of Rehabilitation Medicine, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Gietema JA; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Walenkamp AME; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: a.k.l.reyners@umcg.nl.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2021 Aug; Vol. 58, pp. 138-146. Date of Electronic Publication: 2021 May 15.

Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle.

Autor: Westerink NL; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Nuver J; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Lefrandt JD; Department of Vascular Medicine, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Vrieling AH; Department of Rehabilitation Medicine, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Gietema JA; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Walenkamp AM; Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Electronic address: a.walenkamp@umcg.nl.

Publikováno v: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2016 Dec; Vol. 108, pp. 128-136. Date of Electronic Publication: 2016 Nov 03.

Principles of obstacle avoidance with a transfemoral prosthetic limb.

Autor: van Keeken HG; Center for Human Movement Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Vrieling AH, Hof AL, Postema K, Otten B

Publikováno v: Medical engineering & physics [Med Eng Phys] 2012 Oct; Vol. 34 (8), pp. 1109-16. Date of Electronic Publication: 2011 Dec 22.